Sebastian Bunk

Paul Ehrlich Str. 15
Tuebingen, BW 72076, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Generation of a highly versatile TCR bispecific scaffold optimized for targeting tumor-specific peptide-HLA antigens.

Generation of a highly versatile TCR bispecific scaffold optimized for targeting tumor-specific peptide-HLA antigens.

Journal: mAbs

Published: September 01, 2026

Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial.

Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial.

Journal: Nature medicine

Published: April 29, 2025

Drivers of extended-spectrum β-lactamase (ESBL)- producing Enterobacterales colonization among residents of long-term care facilities: a European multicentre prospective cohort study.

Drivers of extended-spectrum β-lactamase (ESBL)- producing Enterobacterales colonization among residents of long-term care facilities: a European multicentre prospective cohort study.

Journal: The Journal of hospital infection

Published: September 13, 2024

Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial.

Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial.

Journal: Nature medicine

Published: August 05, 2024

First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors.

First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors.

Journal: Journal for immunotherapy of cancer

Published: June 21, 2024

An ultra-high-throughput screen for the evaluation of peptide HLA-Binder interactions.

An ultra-high-throughput screen for the evaluation of peptide HLA-Binder interactions.

Journal: Scientific reports

Published: January 20, 2023

Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy.

Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy.

Journal: Science translational medicine

Published: August 31, 2022

Mammalian Display Platform for the Maturation of Bispecific TCR-Based Molecules.

Mammalian Display Platform for the Maturation of Bispecific TCR-Based Molecules.

Journal: Antibodies (Basel, Switzerland)

Published: April 04, 2022

High-throughput peptide-MHC complex generation and kinetic screenings of TCRs with peptide-receptive HLA-A*02:01 molecules.

High-throughput peptide-MHC complex generation and kinetic screenings of TCRs with peptide-receptive HLA-A*02:01 molecules.

Journal: Science immunology

Published: August 13, 2018

Antigens of persistent Chlamydia pneumoniae within coronary atheroma from patients undergoing heart transplantation.

Antigens of persistent Chlamydia pneumoniae within coronary atheroma from patients undergoing heart transplantation.

Journal: Journal of clinical pathology

Published: November 04, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026